Manage Cancer Risk

Susan Domchek, MD, discussed recent advancements in BRCA-related research. Dr. Domchek is the Basser Center's Executive Director, Basser Professor in Oncology at the University of Pennsylvania, and Director of the Marianne and Robert MacDonald Cancer Risk Evaluation Center.

Kim Reiss Binder, MD, discussed pancreatic cancer and hereditary risk. Dr. Reiss Binder is Assistant Professor of Medicine at the University of Pennsylvania and her research focuses on the development of new treatments for pancreatic cancer and other gastrointestinal malignancies.

Susan Domchek, MD, discussed recent advancements in BRCA-related research. Dr. Domchek is the Basser Center's Executive Director, Basser Professor in Oncology at the University of Pennsylvania, and Director of the Marianne and Robert MacDonald Cancer Risk Evaluation Center.

Basser Center Executive Director Susan Domchek, MD, presented a webinar on cancer genetic testing for physicians and other healthcare providers. She discussed genetic testing for cancer predisposition syndromes; panel testing including BRCA and other genes; genetic research updates, and more.

In this November 5, 2019 webinar, the Basser Center's Director of Gynecologic Cancer Research, Ronny Drapkin, MD, PhD, presented on hereditary ovarian cancer and BRCA. Dr. Drapkin discussed the latest in ovarian cancer research, treatment options, the issue of screening, and more.

Basser Center Executive Director Susan Domchek, MD, presents a webinar on recent advancements in BRCA-related research. Dr. Domchek discusses recent clinical trials and scientific advancements, and breakthroughs in cancer treatment such as current FDA approvals.

Basser Executive Director Susan Domchek, MD, and Allison Werner-Lin, PhD, Associate Professor at Penn Medicine’s School of Social Policy and Practice discuss how to talk to your family about BRCA mutations and hereditary cancer.

In the Basser Center's Annual Research Webinar, Executive Director Susan Domchek, MD, covers the latest updates in hereditary cancer care, BRCA research, and genetics, addressing advances in 2020 and exploring options for the future.